RxDoctor Payments DataLook up a doctor →

Angela Stupi

Rheumatology · Cranberry Twp, PANPI 1619975984

Payments from drug & device makers

$335,865in general payments, 2019–2025

Across 2,406 payments — averaging $139.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$157K
  • Amgen$68K
  • Janssen Research & Development, LLC$21K
  • Bristol Myers Squibb$20K
  • AbbVie$19K
  • Regeneron Healthcare Solutions, Inc.$8K
  • plus $44K from 51 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novartis165$157,425
Amgen(2 entities)509$67,504
Janssen Research & Development, LLC8$20,642
Bristol Myers Squibb38$19,656
AbbVie269$19,185
Regeneron Healthcare Solutions, Inc.29$7,625
Gilead3$7,528
Johnson & Johnson(2 entities)274$5,020
Eli Lilly1$5,000
AstraZeneca(2 entities)85$4,133
UCB, Inc.125$3,118
Pfizer158$2,798
Daiichi Sankyo Inc.105$1,954
GSK88$1,797
Invivyd Inc3$1,663
ANI Pharmaceuticals, Inc.41$1,536
Lilly USA, LLC100$1,456
Mallinckrodt Hospital Products Inc.68$1,373
Aurinia Pharma U.S., Inc.42$1,014
Genentech USA, Inc.68$964
E.r. Squibb & Sons, L.L.C.46$829
Boehringer Ingelheim14$384
Radius Health, Inc.22$371
Mallinckrodt Enterprises LLC10$238
Janssen Scientific Affairs, LLC2$209
Kiniksa Pharmaceuticals International, PLC12$202
Bioventus LLC8$196
Sobi, Inc10$183
Edwards Lifesciences1$171
Organon16$148
Fresenius Kabi USA, LLC7$141
Ferring Pharmaceuticals Inc.6$137
Pacira Therapeutics, Inc.7$136
Collegium Pharmaceutical, Inc.9$131
Hikma Pharmaceuticals USA6$109
Kiniksa Pharmaceuticals, Ltd.5$99
Medexus Pharma, Inc.6$95
Sandoz4$88
Sebela Pharmaceuticals Inc.4$77
Grifols USA, LLC3$72
Sanofi4$63
Actelion Pharmaceuticals US, Inc.4$53
Ultragenyx Pharmaceutical Inc.3$43
ARS Pharmaceuticals Operations, Inc.2$39
Scilex Pharmaceuticals Inc.2$37
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC2$37
Teva Pharmaceuticals USA, Inc.2$25
Takeda Pharmaceuticals U.S.A., Inc.1$25
Alvogen Inc1$23
Shire North American Group Inc1$22
Tonix Medicines, Inc.1$17
Celltrion USA Inc.1$17
Alfasigma USA, Inc.1$14
Octapharma USA, Inc.1$14
Antares Pharma, Inc.1$13
Tersera Therapeutics LLC1$12
Merck1$11

How this compares

$335,865 in reported general payments places this provider in the 90th percentile of 351 rheumatology providers in Pennsylvania.

See all rheumatology providers in Pennsylvania →

Medicare billing

Part B allowed, 2024
$1,984,739
Medicare patients
352
Services billed
114,866

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other rheumatology in Cranberry Twp

See the full list for Pennsylvania →

Where these figures come from

Is this you, or does something look wrong? →